Hisamitsu Pharmaceutical : Earning Document

Hisamitsu Pharmaceutical Co., Inc.

Q3 FY02/2023 Results

This presentation material contains information that constitutes forward- looking statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ from those in the forward-looking statements as a result of various factors including changes in material circumstances.

Hisamitsu Pharmaceutical Co., Inc.

Jan. 12th, 2023

Promoting "TE-A-TE" Culture Worldwide	１

Agenda

1. Looking back on the Q3 FY02/2023
2. Promotion of ESG
3. Progress for FY02/2023
4. Consolidated P&L
5. Sales Results by Region
6. Sales Results by Product
7. Trends of 2nd-generationnon-steroidalanti-inflammatory patch in Japan
8. R&D Pipeline

Promoting "TE-A-TE" Culture Worldwide	２

1. Looking back on the Q3 FY02/2023(1)

Rx Business

OTC Business

Mar. ・FDA Approves Once-Daily XELSTRYM™ (dextroamphetamine) Transdermal System(Theme : ATS) , CII, for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients 6 Years and Older

Apr. ・Application for manufacturing and marketing approval of HP-5070 in Japan (primary palmar hyperhidrosis treatment drug)

Jun. ・Notification of approval for manufacturing and marketing approval of the additional indications of "low back pain, humeroscapular periarthritis, cervico-omo-brachial syndrome and tenosynovitis" for ZICTHORU® Tapes (Transdermal, pain treatment NSAID patch, development code: HP-3150) in Japan

Oct. ・Notification of the Results of the Phase III Clinical Study of HP-5000 for Osteoarthritis Pain of the Knee in the U.S.(Pain Relief and Anti-Inflammatory Patch)

May. ・Launch of Bye Bye Fever® Band fastening type and Cooling Pillow in Japan Jun. ・Launch of new package "Nobinobi® Salonsip® Fit®H(Hot Type)"

"Nobinobi® Salonsip® Fit®α(Odorless type)", 10 patches in Japan

Jun. ・Launch of "Lifecella® SACRISE®" in Japan

Jul. ・Collaboration Campaign between "Hisamitsu Pharmaceutical" and ″Demon Slayer"

in Japan

Sep. ・Launch of new package "Feitas® Shippu", "Feitas® Shippu Onkan", 10 patches in Japan Oct. ・Obtainment of "Good Design Award 2022" for Nobinobi® Salonsip® Fit®

Oct. ・Launch of new package "Salonpas® Tsubokori® Patch", 64 patches in Japan

Promoting "TE-A-TE" Culture Worldwide

３

1. Looking back on the Q3 FY02/2023(2)

Feitas®Shippu, Feitas®Shippu Onkan

Salonpas® Tsubokori® Patch

・Use of package material reduction approximately 21%

・Amount of waste reduction
(2 products total)	approximately 1t/year

Feitas®Shippu https://www.hisamitsu.info/feitas/product/24.html

Feitas®Shippu Onkan https://www.hisamitsu.info/feitas/product/25.html

・Use of package material reduction approximately 3%

・Amount of waste reduction approximately 0.09t/year

Salonpas® Tsubokori® Patch https://www.salonpas.jp/lineup/salonpas_tubokoripatch.html

Promoting "TE-A-TE" Culture Worldwide	４

1. Looking back on the Q3 FY02/2023(3)

Mar. ・Notice regarding Revision of Earnings Forecast
Mar. ・Acquisition of Shares of AYM HD .
	(AYM HD : Wholly-owningparent company of Ayumi Pharmaceutical Holdings .)
Apr. ・Providing Humanitarian Assistance to Ukraine
May. ・Salonpas® certified as the World's No. 1 OTC topical analgesic patch brand for
	the 6th consecutive year since 2016.
	Hisamitsu Pharmaceutical certified as the holder of the world's largest share in
	the corresponding market category for the 5th consecutive year since 2017.
Others	*Based on research by Euromonitor International (UK)
Jul. ・Stock compensation-type stock options (stock acquisition rights) issue
Jul. ・Finalized Stock compensation-type stock options (stock acquisition rights) issue details
Sep. ・Open "Pharmaceutical Research Institute" pavilion at KidZania Fukuoka
Sep. ・Passing away and resignation of an outside director
Sep. ・Support for the heavy rain disaster from August 3, 2022
Sep. ・Construction of New Research Center and Reorganization of Research Sites
Oct. ・Acquisition of treasury stock
Oct. ・Hisamitsu Springs Practice Site Named "Salonpas® Arena"
*Dec.5	Further energy conservation and CO2 reduction efforts through the "Smart Energy Network
	Project" at Kiyohara Industrial Park
*Jan.10 Hisamitsu Pharmaceutical Hot Heart Club decided to donate to support organizations in FY2022
	Promoting "TE-A-TE" Culture Worldwide	５